Clinical Trial: A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093528) titled 'A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD' on July 23.

Brief Summary: To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)

Study Start Date: Aug., 2025

Study Type: OBSERVATIONAL

Condition: Heart Failure With Preserved Ejection Fraction Coronary Microvascular Dysfunction

Intervention: DIAGNOSTIC_TEST: Cardiovascular Magnetic Resonance (CMR)

Patients will consent to undergo a 50-minute non-invasive stress perfusion CMR.

Recruitment Status: NOT_YET_RECRUITING

Spo...